News
Wockhardt Hospitals, Mira Road has initiated a month-long Organ Donor Awareness Campaign, which has started from July 11 and ...
Daxor’s new rapid, lightweight, Blood Volume Analysis system receives US FDA 510(k) clearance: Oak Ridge, Tennessee Monday, August 11, 2025, 18:00 Hrs [IST] Daxor Corporation, t ...
US FDA accepts Arvinas’ NDA for vepdegestrant to treat ESR1m, ER+/HER2- advanced breast cancer: New Haven, Connecticut Monday, August 11, 2025, 17:00 Hrs [IST] Arvinas, Inc., a ...
Exports of Ayush and herbal products for the first three months of FY26 has reported a marginal growth of 0.58%, as compared ...
US FDA approves Nyxoah’s Genio system for the treatment of obstructive sleep apnoea: Mont-Saint-Guibert, Belgium Monday, August 11, 2025, 15:00 Hrs [IST] Nyxoah SA, a medical te ...
BioNTech reaches agreement to get a non-exclusive license for mRNA-based Covid-19 and/or influenza products and resolve patent litigation with CureVac & GSK: Mainz, Germany Monday ...
Our Bureau, Mumbai Monday, August 11, 2025, 16:15 Hrs [IST] Entod Pharmaceuticals, a pioneer in ophthalmic, ENT, and dermatol ...
FOPE with CIPI team-ups with DCGI to foster dialogue and bolster collaboration with pharma sector: Our Bureau, Bengaluru Monday, August 11, 2025, 13:30 Hrs [IST] Federation of Pha ...
Assembly Biosciences announces positive interim results from phase 1b study of ABI-5366, a long-acting helicase-primase inhibitor for HSV type 2 with recurrent genital herpes ...
HOPE & NRx Pharma receive final clearance from Florida's AHCA to proceed to closing of Dura Medical acquisition: Miami Monday, August 11, 2025, 13:00 Hrs [IST] HOPE Therapeutics, ...
Clearmind Medicine reports publication of international patent application for novel combination therapy targeting obesity & high blood sugar: Vancouver, Canada Monday, August 11, ...
L V Prasad Eye Institute (LVPEI) is recognized as one of the leading centres globally for corneal neurotization surgery has performed over 40 procedures, achieving surgical success rates comparable to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results